Andere talen Venus Concept Inc.

Aandelen

VERO

US92332W2044

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,7209 ^USD	-5,14%		-6,94%	-38,91%

08/04	Venus Concept Inc. Kondigt Israëlische wettelijke goedkeuring aan voor Venus Bliss MAX	CI
01/04	Transcript : Venus Concept Inc., Q4 2023 Earnings Call, Apr 01, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing	24/04
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024	15/04
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX	08/04
Venus Concept Inc. Announces Israeli Regulatory Approval for Venus Bliss MAX	08/04
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro	03/04
Venus Concept Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Venus Concept: Q4 Earnings Snapshot	01/04
Venus Concept Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/04
Earnings Flash (VERO) VENUS CONCEPT Posts Q4 Revenue $18.1M	01/04
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results	01/04
Venus Concept Inc. Provides Earning Guidance for the Three Months Ended March 31, 2024	01/04
Venus Concept Continues Listing on Nasdaq, Gets May Deadline to Meet Equity Requirement	25/03
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules	25/03
Certain Options of Venus Concept Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	13/03
Venus Concept Launches “NEXThetics” Program	12/03
Venus Concept Inc. announced that it has received CAD 1.095782 million in funding	07/03
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB	28/02
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	28/02
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	27/02
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI	27/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Venus Concept Inc.

Aandelen

VERO

US92332W2044

Andere talen

Filters